Get started
Work

Supplemental Table 1 from BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer

Year: 2023
Type: supplementary-materials
Abstract: Baseline Patient Characteristics: Serum Biomarker Analysis Group
DOI: 10.1158/1078-0432.22465991.v1
Authors: Al B. Benson, Igor Kiss, John Bridgewater, Ferry A.L.M. Eskens, Carolyn Sasse, Sandra Vossen, Jihong Chen, Chip Van Sant, Howard A. Ball, Anne Keating, Andrew Krivoshik
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361927124
Cites:
Cited by:
Related to: 10